Publications by authors named "Stefan M Czerniecki"

Article Synopsis
  • Organoids from human pluripotent stem cells are valuable for high-throughput screening (HTS), but their complex nature makes automation difficult.
  • A new automated HTS platform streamlines the entire 21-day process of kidney organoid differentiation and analysis, utilizing liquid-handling robots or manual methods.
  • Advanced imaging and single-cell RNA sequencing uncover new cell types in organoids and help assess drug effects, revealing insights like the role of myosin in polycystic kidney disease.
View Article and Find Full Text PDF

Polycystic kidney disease (PKD) is a life-threatening disorder, commonly caused by defects in polycystin-1 (PC1) or polycystin-2 (PC2), in which tubular epithelia form fluid-filled cysts. A major barrier to understanding PKD is the absence of human cellular models that accurately and efficiently recapitulate cystogenesis. Previously, we have generated a genetic model of PKD using human pluripotent stem cells and derived kidney organoids.

View Article and Find Full Text PDF

Background: Loss-of-function mutations in the myotubularin (MTM1) gene cause X-linked myotubular myopathy (XLMTM), a fatal, inherited pediatric disease that affects the entire skeletal musculature. Labrador retriever dogs carrying an MTM1 missense mutation exhibit strongly reduced synthesis of myotubularin, the founder member of a lipid phosphatase required for normal skeletal muscle function. The resulting canine phenotype resembles that of human patients with comparably severe mutations, and survival does not normally exceed 4 months.

View Article and Find Full Text PDF